A patient presents with a platelet count of 700 × 109/L with abnormalitites in size, shape and granularity of platelets. WBC count of 12 × 109L, hemoglobin of 11g/dl and the absence of the Philadelphia chromosome. The most likely diagnosis would be-
## **Core Concept**
The question presents a patient with thrombocytosis (elevated platelet count), abnormalities in platelet morphology, a mild leukocytosis (elevated WBC count), and a mild anemia (low hemoglobin). The absence of the Philadelphia chromosome helps to narrow down the differential diagnosis. This combination of findings suggests a myeloproliferative neoplasm (MPN).
## **Why the Correct Answer is Right**
The correct answer, **Essential Thrombocythemia (ET)**, is a type of myeloproliferative neoplasm characterized by the overproduction of platelets, often with abnormalities in platelet size, shape, and granularity. Patients with ET may also have a mild increase in white blood cell count and a mild decrease in hemoglobin. The absence of the Philadelphia chromosome is a key feature that distinguishes ET from Chronic Myeloid Leukemia (CML), as CML is characterized by the presence of the Philadelphia chromosome, which results from a translocation between chromosomes 9 and 22.
## **Why Each Wrong Option is Incorrect**
- **Option A: Chronic Myeloid Leukemia (CML)**. CML is typically associated with the presence of the Philadelphia chromosome, which is not found in this patient. While CML can present with thrombocytosis, the absence of the Philadelphia chromosome makes this diagnosis unlikely.
- **Option B: Polycythemia Vera (PV)**. PV is another myeloproliferative neoplasm, but it is primarily characterized by an increase in red blood cell mass, which is not indicated here by the provided hemoglobin level alone. However, some patients with PV can have a relatively low red cell mass and still present with elevated platelets and white cells.
- **Option D: Primary Myelofibrosis (PMF)**. PMF can present with abnormalities in blood cell counts, including thrombocytosis, but it often includes more significant changes such as marked splenomegaly, and in advanced stages, a decrease in platelet count due to bone marrow fibrosis.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the **absence of the Philadelphia chromosome** significantly influences the diagnosis in cases of myeloproliferative neoplasms. Essential Thrombocythemia (ET) is often considered a diagnosis of exclusion, requiring the exclusion of other causes of thrombocytosis and the presence of specific diagnostic criteria, including the absence of the Philadelphia chromosome and other diagnostic molecular markers.
## **Correct Answer:** . **Essential Thrombocythemia**